Medicare Enrolled
Dr. James Gordon, M.D.
Ophthalmology · Armonk, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gordon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gordon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gordon
Dr. James Gordon is an ophthalmology specialist in Armonk, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gordon performed 13,884 Medicare services across 2,359 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gordon received a total of $8,627 from 38 pharmaceutical and/or device companies across 420 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gordon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NY
$8,627 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,884
Medicare services
Top 5% in NY for ophthalmology
2,359
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~694 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| AbobotulinumtoxinA injection, 5 units An injection of abobotulinumtoxinA administered in a quantity of 5 units. |
11,150 | $2 | $3 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
902 | $100 | $350 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
349 | $75 | $182 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
222 | $22 | $418 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
169 | $55 | $178 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
150 | $19 | $115 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
136 | $113 | $250 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
135 | $21 | $61 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
108 | $505 | $1,830 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
81 | $27 | $125 |
| Eye photography Photographic imaging of the interior structures of the eye. |
69 | $19 | $125 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
57 | $33 | $126 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $109 | $211 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
39 | $153 | $500 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
37 | $10 | $100 |
| New patient eye exam, problem focused A focused examination of the visual system performed during a new patient visit. |
36 | $65 | $179 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $84 | $225 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
31 | $299 | $1,874 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
31 | $32 | $150 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
27 | $13 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $146 | $303 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
14 | $688 | $1,650 |
| Eyelid drooping or paralysis tissue removal A surgical procedure to remove tissue, muscle, and membrane to correct eyelid drooping or paralysis. |
13 | $407 | $2,500 |
| Removal of excessive skin and fat of upper eyelid | 11 | $712 | $1,500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
81.6% medium
17.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,627
Total received (2018-2024)
Avg $1,232/year across 7 years
Top 12% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
420
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,627 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,275
2023
$999
2022
$1,626
2021
$1,838
2020
$904
2019
$1,127
2018
$858
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$671
RxSight Inc
$169
Oyster Point Pharma, Inc.
$167
Bausch & Lomb Americas Inc.
$63
Amgen Inc.
$61
SUN PHARMACEUTICAL INDUSTRIES INC.
$55
Tarsus Pharmaceuticals, Inc.
$37
ABBVIE INC.
$20
Boston Scientific Corporation
$19
Alimera Sciences, Inc.
$14
Top 3 companies account for 78.9% of 2024 payments
All-time payments by company (2018-2024) ›
Alcon Vision LLC
$2,178
Kala Pharmaceuticals, Inc.
$1,251
Novartis Pharmaceuticals Corporation
$984
ABBVIE INC.
$614
Horizon Therapeutics plc
$375
Sun Pharmaceutical Industries Inc.
$311
Aerie Pharmaceuticals, Inc.
$310
Allergan, Inc.
$263
Oyster Point Pharma, Inc.
$233
EyePoint Pharmaceuticals US, Inc.
$203
RxSight Inc
$169
NEW WORLD MEDICAL,INC.
$150
Merz North America, Inc.
$149
SUN PHARMACEUTICAL INDUSTRIES INC.
$142
Bausch & Lomb, a division of Bausch Health US, LLC
$142
Alimera Sciences, Inc.
$136
Beaver-Visitec International, Inc.
$122
Alcon Laboratories Inc
$108
Allergan Inc.
$106
Shire North American Group Inc
$105
Bausch & Lomb Americas Inc.
$88
Johnson & Johnson Surgical Vision, Inc.
$73
Amgen Inc.
$61
GENZYME CORPORATION
$54
Sight Sciences, Inc.
$50
Tarsus Pharmaceuticals, Inc.
$37
Rayner Intraocular Lenses Limited
$26
AbbVie Inc.
$25
Eyevance Pharmaceuticals LLC
$25
Baudax Bio Inc.
$23
Galderma Laboratories, L.P.
$20
Boston Scientific Corporation
$19
Dompe US, Inc.
$16
Ocular Therapeutix, Inc.
$14
Alcon Research LLC
$12
Spark Therapeutics, Inc.
$12
Johnson & Johnson Vision Care, Inc.
$11
NovaBay Pharmaceuticals, Inc.
$11
Top 3 companies account for 51.2% of all-time payments
Associated products mentioned in payments ›
ACTIVEFOCUS · ANJESO · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · Acuvue · Avenova · BROMSITE · CEQUA · COMBIGAN · Cequa · Clareon · DEXTENZA · DEXYCU · DUREZOL · DURYSTA · EYSUVIS · FABRY-DISEASE · HUMIRA · ILEVRO · ILUVIEN · ILUX · INVELTYS · Iluvien · Kahook Dual Blade · LOTEMAX SM · LUMIGAN · LUXTURNA · MIEBO · OMNI(R) SURGICAL SYSTEM (US) · ORA · OXERVATE · Omidria · PAZEO · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · ReSTOR · Rhopressa · Rocklatan · Simbrinza · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare · Tecnis 1-piece IOL · Tecnis Multifocal Family of 1-piece IOLS · VUITY · VYZULTA · XDEMVY · XELPROS · XEOMIN · XIIDRA · YUTIQ · Zerviate · enVista MX60 IOL · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Ophthalmologists within 10 mi
514
Per 100K population
51.6
County median income
$118,411
Nearest hospital
WESTCHESTER MEDICAL CENTER
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gordon is a mixed practice specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement in the top 12% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gordon experienced with abobotulinumtoxina injection, 5 units?
Based on Medicare claims data, Dr. Gordon performed 11,150 abobotulinumtoxina injection, 5 units services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gordon receive payments from pharmaceutical companies?
Yes. Dr. Gordon received a total of $8,627 from 38 companies across 420 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gordon's costs compare to other ophthalmologists in Armonk?
Dr. Gordon's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gordon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Armonk
Browse ophthalmologists in Armonk ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in NY
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in NY
Which NY ophthalmologists receive the most from drug and device companies.
By company
Alcon Vision LLC Payments to Doctors
See all physicians who received payments from Alcon Vision LLC.
By company
Kala Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Kala Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology